Compare Stocks

AEX Gold Inc. engages in the acquisition, exploration, and development of mineral properties in Greenland. It holds interests in licenses covering an area of 7,615.85 square kilometers located in South Greenland. The company was formerly known as Alopex Gold Inc. and changed its name to AEX Gold Inc. in June 2018. AEX Gold Inc. was incorporated in 2017 and is headquartered in Toronto, Canada.

Star Diamond Corporation engages in the exploration, development, and production of diamonds in Canada. The company's principal mineral properties include the Star Kimberlite property and the Orion South Kimberlite property located in Fort à la Corne area of Saskatchewan, Canada. It also holds a 50% interest in the Buffalo Hills project located in north central Alberta, Canada. The company was formerly known as Shore Gold Inc. and changed its name to Star Diamond Corporation in February 2018. The company was incorporated in 1985 and is headquartered in Saskatoon, Canada.

Erdene Resource Development Corporation focuses on the acquisition, exploration, and development of precious and base metal deposits in Mongolia. The company explores for copper, molybdenum, gold, silver, lead, and zinc deposits. Its principal projects are the Bayan Khundii Gold project and the Altan Nar Gold-Polymetallic project located in southwest Mongolia. The company was formerly known as Erdene Gold Inc. and changed its name to Erdene Resource Development Corporation in May 2008. Erdene Resource Development Corporation was incorporated in 2000 and is headquartered in Dartmouth, Canada.

Hospira, Inc. provides injectable pharmaceutical drugs and infusion technologies and it develops, manufactures, distributes and markets biosimilars. The Company's portfolio includes generic acute-care and oncology injectables, biosimilars, and integrated infusion therapy and medication management products. The Company conducts operations across the world and is managed in three segments: the Americas, which include the United States, Canada, and Latin America; Europe, Middle East, and Africa (EMEA), and the Asia Pacific, which includes Asia, Japan, Australia and New Zealand. Its portfolio of products includes Specialty Injectable Pharmaceuticals, which includes generic injectables, injectables and biosimilars, Medication Management and Other Pharmaceuticals. Its portfolio of products is used by hospitals and alternate site providers, such as clinics, home healthcare providers and long-term care facilities.

Voya Natural Resources Equity Income Fund is a closed-ended equity mutual fund launched by Voya Investment Management LLC. The fund is co-managed by Voya Investments, LLC and Voya Investment Management Co. LLC. It invests in the public equity markets of North America. The fund seeks to invest in stocks of companies operating in the energy, natural resources, and basic materials industries. It primarily invests in growth and value stocks of companies. The fund also invests through derivatives linked to the equity securities such as call options. It employs fundamental analysis with proprietary stock selection screens, focusing on such factors as cash flows, earnings, price-to-book ratios, superior capital allocation, and strong competitive position, and operations to create its portfolio. The fund benchmarks the performance of its portfolio against the S&P North American Natural Resources Sector Index. It was formerly known as ING Risk Managed Natural Resources Fund. Voya Natural Resources Equity Income Fund was formed on October 24, 2006 and is domiciled in the United States.